Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient-Reference-Cited by-同舟云学术

Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient

Published:2023-06-27 Issue:1 Volume:34 Page:
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Zhang Shiyu¹,Lu Lu¹,Feng Jindi¹,Hu Zhonghui¹,Song Hongbin¹,Yang Lu¹,Liu Yuehua¹,Chen Di²,Wang Tao¹

Affiliation:

1. Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, P.R. China

2. Department of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, P.R. China

Funder

National High Level Hospital Clinical Research Funding

Beijing Natural Science Foundation

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2023.2229466

Reference15 articles.

1. Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis

2. Dupilumab-associated ocular manifestations: A review of clinical presentations and management

3. A method for estimating the probability of adverse drug reactions

4. A case report of uveitis secondary to dupilumab treatment for atopic dermatitis

5. Association of dupilumab with intraocular inflammation;Padidam S;Ocul Immunol Inflamm,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities;Journal of Leukocyte Biology;2024-03-08

2. Focus on biological therapies in pediatric allergy;Global Pediatrics;2024-03

3. Dupilumab;Reactions Weekly;2023-07-22